BS
Barney Stinson, Ph.D.
Computational single-cell scientist moving into connectome-scale neuroscience
Boston, MA 02135
(555) 019-2847
barney.stinson@example.com
Google Scholar
barneystinson.example.com/cv
Profile
Moving from wet-lab immunology into computational neuroscience. I build methods that infer cellular identity, state, and interaction from large, incomplete single-cell and spatial data. Research objective: connect molecular cell identity to circuit structure and function by integrating connectomics with transcriptomics, growing into connectome-constrained circuit models.
Experience
Postdoctoral Researcher2025–2026
Nakdong University Wonju College of Medicine · Physiology / Cellular Systems Research Center
Developed deep-learning multimodal-integration models fusing imaging, transcriptomic, and clinical data into single predictive models.
Associate Director2023–2025
Meridian Immune Therapeutics Inc. · Basic Research, Seoul
Built in-house single-cell & spatial transcriptomics analysis code from scratch; led cross-functional NHP (cynomolgus, marmoset) EAE/MS multi-omic studies; oversaw regulatory documentation for an anti-CD25 humanized-antibody program.
Researcher2019–2021
Xenotransplantation Research Center, HNU · Seoul
Rhesus macaque tissue processing, longitudinal immune monitoring, CNS (brain/spinal cord) tissue handling.
Research Student, MOSAIC2020–2023
Multi-Organ Single-cell Atlas of Immune Cells, HNU
Contributed the founding proposal; executed within the funded program (500+ donors × 6 organs): milestone tracking, multi-site QC, multi-PI coordination.
Education
Ph.D., Biomedical Sciences2014–2023
Hangang National University · Seoul
Mapping Dendritic Cell Heterogeneity Across Chronic Inflammatory Contexts. Advisor: Min-Ho Suh, M.D., Ph.D.
M.S., Biomedical Sciences2012–2014
Hangang National University · Seoul
Enhanced LPS-Induced Monocyte Activation by Recombinant Human Soluble CD180.
B.S., Genetic Engineering2008–2012
Suwon Institute of Life Sciences · Suwon
Strengths
◆Method-building from scratch
Wrote custom UMI-aware BAM-level isoform code (Python) that resolved PDE9X isoform identity from 5′ scRNA-seq; built in-house single-cell and spatial pipelines end to end.
◆Multimodal integration
Fused imaging, transcriptomic, and clinical data into single predictive models; combined scRNA, scTCR, and snATAC across a 702-sample meta-analysis.
◆Cross-species, cross-team execution
Led NHP EAE/MS multi-omic studies and coordinated a 700+ donor, 8-organ atlas program across multiple sites and PIs.
Skill Proficiency
Single-cell / spatial omics★★★★★
Python ML / deep learning★★★★★
Multimodal DL integration★★★★★
Flow cytometry / FACS★★★★★
Reproducible analysis (R, Git)★★★★★
Technical Skills
Single-cell / spatial / multi-omicSeurat, Scanpy, Squidpy, Monocle3, CellChat/NicheNet; scVI/scANVI, consensus NMF; Milo, GLIPH, InferCNV; GeoMx DSP; Olink proteomics.
ML / DL / AIscikit-learn, XGBoost/LightGBM/CatBoost, PyTorch; VAE/GAN/GNN; AlphaFold2/3, ProteinMPNN, DiffDock, MolFormer.
Experimental10x 5′/3′ scRNA + scTCR; 24-marker flow; brain/CNS immune profiling; IHC/IF; two-photon; NHP CNS tissue.
Selected Publications
1Reyes M*, Stinson B*, Alvarez T*, et al. Conserved PDE9X short-isoform bias defines pathogenic Th1.17 state across human inflammatory diseases. Nature Immunology IF 27.7 · under review, 2026. ML classifier AUC 0.812; 702 samples, 251,055 CD4⁺ T cells.
2Stinson B*, Tanaka Y*, Truong P*, et al. Immune cell-enriched scRNA-seq unveils infiltrated CD8⁺ T resident memory cells and meningeal lymphatic endothelium in Parkinson's disease. Journal of Neuroimmunology IF 2.9 · 2025. 11,587 cells.
3Stinson B*, Delgado J*, Moreau S, et al. Deciphering Dysfunctional Regulatory T Cells in Vitiligo. Allergy IF 12.6 · 2025.
4Alvarez J*, Stinson B*, et al. Long-term control of diabetes by a baricitinib-based regimen after allo-islet transplantation in rhesus monkeys. Xenotransplantation IF 3.9 · 2024.
5Novak L*, Stinson B*, et al. Intra-tumoral heterogeneity and immune escape of melanoma from chronic UV photodamage by spatial gene expression. JEADV IF 9.2 · 2022.
6Stinson B*, et al. mTOR inhibitor-based immunosuppression in allogeneic islet transplantation. Islets IF 2.2 · 2019. Co-author: eBioMedicine (2024), JEADV (2024), Curr. Diabetes Reports (2021).
Awards & Patents
2024Patent: Antagonistic Anti-CD25 Humanized Antibody (No. 1020240091845).
2019Patent: Immunosuppression Composition Comprising PI3K Inhibitor (No. 1020143496217).
2024Grand Prize, AI Builders Hackathon (Project Nova Team).
2023Grand Prize, Metro Innovation Workathon.
2017Best Poster, American Transplant Congress; Best Presentation, KAI.
2014–20NRF Ph.D. Scholarship · BK21 Plus · HNU Dean's Support.
References
Min-Ho Suh, M.D., Ph.D.
HNU College of Medicine; CEO/CSO, Meridian Immune Therapeutics. Ph.D. advisor.
mhsuh@hangang.ac.krJi-Won Baek, M.D., Ph.D.
HNU, Microbiology & Immunology / IBRI. Computational co-corresponding.
jwbaek@hangang.ac.kr